NCT02270034 - Study to Evaluate Safety and Activity of Crizotinib With Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 13, 2014

Primary Completion Date

October 26, 2020

Study Completion Date

October 26, 2020

Conditions

Glioblastoma Multiforme (Grade IV) of Cerebellum

Interventions

DRUG

Crizotinib

Crizotinib is added to Stupp method

Trial Locations (4)

Hospital Universitario 12 de Octubre, Madrid

Institut Català D'Oncologia L'Hospitalet (Ico), L'Hospitalet de Llobregat

Hospital Del Mar, Barcelona

Hospital Clínic de Barcelona, Barcelona